AI-Powered Tool Combs through Electronic Health Records For Faster Diagnoses of Rare Diseases
By HospiMedica International staff writers Posted on 05 Jul 2024 |

A rare disease is defined as one that affects fewer than 200,000 individuals. Collectively, over 10,000 known rare diseases impact more than 30 million people. While some of these diseases, like multiple sclerosis, are well-recognized, most—including bartonellosis, maple syrup urine disease, and visual snow syndrome—are not. Acute hepatic porphyria (AHP), a group of rare genetic disorders, affects 1 in 100,000 people, predominantly women. The symptoms often correlate with the menstrual cycle and can lead to severe, even life-threatening, episodes characterized by abdominal pain, nausea, vomiting, limb weakness, and anxiety. In 2019, the FDA approved givosiran as a prophylactic treatment for these recurrent attacks. However, the average time to diagnose AHP is 15 years, largely because physicians encounter it so infrequently. During this diagnostic delay, the disease can worsen and cause irreversible harm. Now, researchers have created an artificial intelligence (AI) tool that can identify potential patients with AHP, thus aiding in the diagnosis and management of this rare genetic disease.
This predictive algorithm developed by the team at UCLA Health (Los Angeles, CA, USA) under Project Zebra, sifts through electronic health records to spot patterns indicative of disease, alerting physicians to patients who may need further testing and diagnosis. It specifically targets suspected porphyria patients and was trained on a dataset that included de-identified patient records from UCSF and UCLA—part of approximately 10 million records throughout the UC system. The algorithm's development was complicated by the often lengthy approval process required for accessing patient data, and the fact that algorithms improve with access to vast datasets from various institutions, though obtaining the necessary permissions can be challenging. To overcome this, zebraMD has implemented Virtual Pooling, a patented technology that allows the algorithm to learn from data without actually transferring it.
One of the main hurdles in developing the algorithm was the unorganized nature of patient data, which includes both structured data, like vital signs and lab results, and unstructured data, such as physician's notes. The latter presents particular difficulties for algorithms, which prompted the researchers to refine and structure the data. The researchers equipped the model with detailed symptom information and references to a rare and genetic disease database maintained by the National Institutes of Health, which catalogs signs, symptoms, and clinical presentation of diseases including porphyria. The algorithm was then allowed to independently scan through the data and identify patterns, an approach that is crucial given the high rate of misdiagnosis associated with rare diseases. According to findings published in the Journal of the American Medical Informatics Association, the algorithm accurately predicted referrals for AHP testing with an accuracy between 89% and 93%, and it identified 71% of the patients who tested positive for the disease earlier than they were actually diagnosed, saving an average of 1.2 years per case. Currently, Project Zebra is expanding its focus to include predicting cerebral aneurysms, a potentially life-threatening condition characterized by the expansion of a weakened blood vessel in the brain.
“I hope that at some point this is a standard feature of any electronic health records system,” said Katharina “Kat” Schmolly, MD, a UCLA medical student who co-created the algorithm. “The more patients we can diagnose, the more we can monitor over time. That means we can learn what works and what doesn't work. We can create precision medicine approaches for these rare diseases. Many of them don't have any treatments yet. So hopefully, we can find new treatment options for them.”
Related Links:
UCLA Health
Latest Critical Care News
- Novel Coating Significantly Extends Longevity of Implantable Biosensors
- Nanogel-Based Drug Delivery Technology to Improve UTI Treatment
- New IV Pole Improves Safety and Ease of Administering IV Medications at Hospital Bedside
- Battery-Powered Wearable Device Monitors Joint Pain
- Wireless Pacifier Monitors Vitals of NICU Babies Without Need for Painful Blood Draws
- Breakthrough Sensor Technology Tracks Stroke After Effects
- New Study Demonstrates AI-Assisted Detection of Reduced Ejection Fraction
- Novel 3D Adipose Tissue Bioprinting Method to Find Applications in Regenerative Medicine
- Miniaturized Pacemaker for Newborns Found Safe and Effective for Up to Two Years
- World’s First 3D Neural Electrode Uses Soft Actuation Technology to Avoid Nerve Damage
- Smartwatch Algorithm Detects Cardiac Arrest
- Blood-Brain Barrier “Organ Chip” Treats Brain Tumors Unreachable by Chemotherapy
- AI Model Could Use ECG Tests to Detect Premature Aging and Cognitive Decline
- World-First Technology Uses Real-Time ECG Signal Analysis for Accurate CVAD Placement
- AI Outperforms Humans at Analyzing Long-Term ECG Recordings
- Smart Sensor Enables Precise, Self-Powered Tracking of Healing Wounds
Channels
Artificial Intelligence
view channel
Innovative Risk Score Predicts Heart Attack or Stroke in Kidney Transplant Candidates
Heart researchers have utilized an innovative risk assessment score to accurately predict whether patients being evaluated for kidney transplants are at risk for future major cardiac events, such as a... Read more
AI Algorithm Detects Early-Stage Metabolic-Associated Steatotic Liver Disease Using EHRs
Liver disease, which is treatable when detected early, often goes unnoticed until it reaches advanced stages. Metabolic-associated steatotic liver disease (MASLD), the most prevalent form of liver disease,... Read moreSurgical Techniques
view channel
Easy-To-Apply Gel Could Prevent Formation of Post-Surgical Abdominal Adhesions
Surgical adhesions are a frequent and often life-threatening complication following open or laparoscopic abdominal surgery. These adhesions develop in the weeks following surgery as the body heals.... Read more
Groundbreaking Leadless Pacemaker to Prevent Invasive Surgeries for Children
Leadless pacemakers marked a significant advancement in cardiac care, primarily because traditional pacemakers are dependent on leads, which are prone to breakage over time. Currently, two FDA-approved... Read morePatient Care
view channel
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more
Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more
Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
A groundbreaking innovation enables hospitals to significantly improve instrument processing time and throughput in operating rooms (ORs) and sterile processing departments. Turbett Surgical, Inc.... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read morePoint of Care
view channel
Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour
Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Smartphone-Enabled, Paper-Based Quantitative Diagnostic Platform Transforms POC Testing
Point-of-care diagnostics are crucial for public health, offering rapid, on-site testing that enables prompt diagnosis and treatment. This is especially valuable in remote or underserved regions where... Read moreBusiness
view channel
Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business
Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA), has announced that its board of directors has unanimously authorized BD management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more